World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 73 2088 1915 183 176 301 28245

Mark S. Cragg publications per year

The chart shows the history of publications by Mark S. Cragg between 1999 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark S. Cragg published across 27 years, from 1999 to 2025, averaging 14.7 papers a year. Output peaked at 55 publications in 2023. 63 of the 397 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1999 to 2025. Vertical axis: number of publications, 0 to 55. Peak 55 publications in 2023. 1999: 4 publications 2000: 5 publications 2001: 1 publication 2002: 2 publications 2003: 4 publications 2004: 5 publications 2005: 6 publications 2006: 5 publications 2007: 3 publications 2008: 10 publications 2009: 8 publications 2010: 13 publications 2011: 11 publications 2012: 8 publications 2013: 15 publications 2014: 16 publications 2015: 25 publications 2016: 24 publications 2017: 25 publications 2018: 17 publications 2019: 10 publications 2020: 31 publications 2021: 20 publications 2022: 11 publications 2023: 55 publications 2024: 16 publications 2025: 47 publications
1999 2025

397 publications in total across all disciplines

View publications per year as a table
Mark S. Cragg: publications per year, 1999 to 2025
Year Publications
1999 4
2000 5
2001 1
2002 2
2003 4
2004 5
2005 6
2006 5
2007 3
2008 10
2009 8
2010 13
2011 11
2012 8
2013 15
2014 16
2015 25
2016 24
2017 25
2018 17
2019 10
2020 31
2021 20
2022 11
2023 55
2024 16
2025 47
Total 397
Download as CSV

Mark S. Cragg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark S. Cragg sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 292–301 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 301 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111 301
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Mark S. Cragg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Cragg sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 72–73 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184 73
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Mark S. Cragg is affiliated with the University of Southampton in the United Kingdom and has contributed extensively to biomedical research, focusing primarily on medicine and immunology. Their publication record spans multiple subfields, including immunology, radiology, oncology, molecular biology, and genetics.

The main fields of study for this researcher are:

  • Medicine
  • Immunology and Microbiology

Subfields where Mark S. Cragg has published include:

  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Molecular Biology
  • Genetics

The research topics frequently covered by Mark S. Cragg encompass:

  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment

Recent papers authored or co-authored by Mark S. Cragg include:

  • Reducing affinity as a strategy to boost immunomodulatory antibody agonism, 2023, Nature
  • Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathology, 2021, Cell Reports
  • Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment, 2020, Antibodies
  • Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity, 2020, Immunity
  • Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma, 2020, Blood Advances

Mark S. Cragg frequently collaborates with several researchers, including:

  • Stephen A. Beers
  • Björn Frendéus
  • Robert Oldham
  • H. T. Claude Chan
  • Tatyana Inzhelevskaya

The primary venues for their publications include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Blood Advances
  • Frontiers in Immunology
  • Journal for ImmunoTherapy of Cancer

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

    Jessica L Teeling;Ruth R French;Mark S Cragg;Jeroen van den Brakel

  • Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain

    Katharine Askew;Kaizhen Li;Adrian Olmos-Alonso;Fernando Garcia-Moreno

  • Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

    Mark S Cragg;Suzanne M Morgan;H T Claude Chan;B Paul Morgan

  • Mechanisms of killing by anti-CD20 monoclonal antibodies.

    Martin J. Glennie;Ruth R. French;Mark S. Cragg;Ronald P. Taylor

  • Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents.

    Mark S. Cragg;Martin J. Glennie

  • The biology of CD20 and its potential as a target for mAb therapy.

    Mark S. Cragg;Claire A. Walshe;Andrey O. Ivanov;Martin J. Glennie

  • Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

    Stephen A. Beers;Ruth R. French;H. T. Claude Chan;Sean H. Lim

  • Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics

    Mark S Cragg;Junya Kuroda;Hamsa Puthalakath;David C. S Huang

  • Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

    Junya Kuroda;Hamsa Puthalakath;Mark S. Cragg;Priscilla N. Kelly;Priscilla N. Kelly

  • Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

    Waleed Alduaij;Andrei Ivanov;Jamie Honeychurch;Eleanor J Cheadle

  • Anti-CD20 monoclonal antibodies: historical and future perspectives

    Sean H. Lim;Stephen A. Beers;Ruth R. French;Peter W.M. Johnson

  • Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

    Sean H Lim;Andrew T Vaughan;Margaret Ashton-Key;Emily L Williams

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts

    H T Claude Chan;David Hughes;Ruth R French;Alison L Tutt

  • CD20 as a target for therapeutic type I and II monoclonal antibodies.

    Stephen A. Beers;Claude H.T. Chan;Ruth R. French;Mark S. Cragg

  • Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathology.

    Yanling Hu;Gemma L. Fryatt;Mohammadmersad Ghorbani;Juliane Obst

  • Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody

    Ann L. White;H. T. Claude Chan;Ali Roghanian;Ruth R. French

  • Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics

    Mark S. Cragg;Claire Harris;Claire Harris;Andreas Strasser;Clare L. Scott;Clare L. Scott

  • Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic

    Mark S. Cragg;Elisa S. Jansen;Michele Cook;Claire Harris

Frequent Co-Authors

Martin J. Glennie
Martin J. Glennie University of Southampton
Peter Johnson
Peter Johnson University of Southampton
Graham Packham
Graham Packham University of Southampton
Aymen Al-Shamkhani
Aymen Al-Shamkhani University of Southampton
David Oscier
David Oscier Royal Bournemouth Hospital
Paul A. Townsend
Paul A. Townsend University of Manchester
Freda K. Stevenson
Freda K. Stevenson University of Southampton
J. Sjef Verbeek
J. Sjef Verbeek Leiden University Medical Center
Andreas Strasser
Andreas Strasser Walter and Eliza Hall Institute of Medical Research
Christian Klein
Christian Klein Roche (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career opportunities. Nursing programs, especially those leading to advanced practice roles, often align well with immunology knowledge and patient care.

Students can find programs tailored to different career stages, from entry-level LPNs to advanced nurse practitioners. The easiest lpn programs to get into offer accessible pathways for those starting in healthcare and looking to build foundational skills quickly.

For advanced degrees, understanding what makes a program manageable is important. Discovering what is the easiest np program can help prospective students select programs that balance rigor with completion feasibility.

Specializing in areas like psychiatric mental health nursing is another growing field. Identifying the best online psychiatric mental health nurse practitioner programs ensures excellent clinical experiences, a critical component for skill development.

Cost-efficiency is key for many working professionals. Exploring cheap psych np programs can provide affordable routes without compromising educational quality.

Best Scientists Citing Mark S. Cragg

Trending Scientists

Recently Published Articles